Efficacy of risedronate in men with primary and secondary osteoporosis: Results of a 1-year study

Rheumatology International

Volumn 26, Issue 5, 2006, Pages 427-431

  Ringe, J D ^a   Faber, H ^a   Farahmand, P ^a   Dorst, A ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Bisphosphonates; Male; Non vertebral fracture; Osteoporosis; Risedronate; Vertebral fracture

Indexed keywords

ALFACALCIDOL; CALCIUM; RISEDRONIC ACID; VITAMIN D;

ADULT; AGED; ARTICLE; BACKACHE; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; FOLLOW UP; HIP; HUMAN; INCIDENCE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PRIMARY OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY OSTEOPOROSIS; SELF EVALUATION; SIDE EFFECT; TREATMENT OUTCOME; VERTEBRA FRACTURE;

AGED; BACK PAIN; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CALCIUM; ETIDRONIC ACID; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PROSPECTIVE STUDIES; SPINE; VITAMIN D;

EID: 33644616548     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-005-0004-4     Document Type: Article

References (21)

1. Barrett-Connor E (1995) The economic and human costs of osteoporotic fracture. Am J Med 98(2A):3S-8S
2. Campion JM, Maricic MJ (2003) Osteoporosis in men. Am Fam Physician 67(7):1521-1526
3. Center JR et al (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353(9156):878-882
4. Olszynski WP et al (2004) Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment. Clin Ther 26(1):15-28
5. Kiebzak GM et al (2002) Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 162(19):2217-2222
6. Nguyen TV, Center JR, Eisman JA (2004) Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust 180(5 Suppl):S18-S22
7. Snyder PJ et al (2000) Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 85(8):2670-2677
8. Orwoll E et al (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343(9):604-610
9. Ringe JD, Orwoll E, Daifotis A, Lombardi A (2002) Treatment of male osteoporosis: recent advances with alendronate. Osteoporos Int 13:195-199
10. Ringe JD, Dorst A, Faber H, Ibach K (2004) Alendonate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study. Rheumatol Int 24:110-113
11. Physicians' desk reference: PDR (2003) 57th edn. Thomson PDR, Montvale, p 3550
12. Roux C et al (2004) Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin 20(4):433-439
13. Harrington T et al (2004) Risedronate rapidly reduces the risk for non-vertebral fractures in women with postmenopausal osteoporosis. Calcif Tissue Int 74:129-135
14. McClung MR et al (2001) Effect of risedronate on the risk of hip fracture in elderly women Hip Intervention Program Study Group. N Engl J Med 344(5):333-340
15. Reid DM et al (2001) Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy. Calcif Tissue Int 69(4):242-247
16. Lindsay R et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320-323
17. Ringe JD (2000) Osteoporosis in men. In: Hosking D, Ringe J (eds) Treatment of metabolic bone disease. Management strategy and drug therapy. Martin Dunitz, London
18. Hasserius R et al (2003) Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int 4(1):61-68
19. Ross PD et al (1991) Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114(11):919-923
20. Harris ST et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282(14):1344-1352
21. Reginster J et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11(1):83-91